Robin Jason, | |
3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 | |
(248) 551-9248 | |
Not Available |
Full Name | Robin Jason |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 33 Years |
Location | 3601 W 13 Mile Rd, Royal Oak, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912966367 | NPI | - | NPPES |
300F362420 | Other | MI | BCBSM |
4073121 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 4301057970 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
News Archive
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has been recognized as a winner of the Microsoft® Healthcare Users Group (MS-HUG) 2010 Innovation Awards in the category of Interoperability/HIE.
UT Southwestern Medical Center researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression.
Electronic tools and technology applications for consumers can help improve health care processes, such as adherence to medication and clinical outcomes like smoking cessation, according to a report by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at the University of North Carolina at Chapel Hill and partners have found strong evidence that rates of heat-related illnesses, such as heat cramps and heat strokes, were reduced by half in states that had mandated guidelines to reduce exertional heat illness among high school football players.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
› Verified 8 days ago
Entity Name | Beaumont Medical Group Hospital Based Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has been recognized as a winner of the Microsoft® Healthcare Users Group (MS-HUG) 2010 Innovation Awards in the category of Interoperability/HIE.
UT Southwestern Medical Center researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression.
Electronic tools and technology applications for consumers can help improve health care processes, such as adherence to medication and clinical outcomes like smoking cessation, according to a report by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at the University of North Carolina at Chapel Hill and partners have found strong evidence that rates of heat-related illnesses, such as heat cramps and heat strokes, were reduced by half in states that had mandated guidelines to reduce exertional heat illness among high school football players.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Robin Jason, 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: (947) 522-1860 | Robin Jason, 3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 Ph: (248) 551-9248 |
News Archive
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has been recognized as a winner of the Microsoft® Healthcare Users Group (MS-HUG) 2010 Innovation Awards in the category of Interoperability/HIE.
UT Southwestern Medical Center researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression.
Electronic tools and technology applications for consumers can help improve health care processes, such as adherence to medication and clinical outcomes like smoking cessation, according to a report by researchers at the Johns Hopkins Bloomberg School of Public Health.
Researchers at the University of North Carolina at Chapel Hill and partners have found strong evidence that rates of heat-related illnesses, such as heat cramps and heat strokes, were reduced by half in states that had mandated guidelines to reduce exertional heat illness among high school football players.
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
› Verified 8 days ago
Terrence Metz, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 | |
Christopher W Keyes, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7266 | |
Stephen Hudak, Radiology Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6262 | |
Elias Antypas, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. Derek Alexander Mumaw, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6347 | |
Kent Donovan, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. John Douglas Ebersole, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6064 |